OPROVDA
Live / Allowed — Notice of allowance issued (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99804604
- Mark type
- Stylized text
- Filed
- 05 May 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorder; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; Pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 08 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2026 — ASSIGNED TO EXAMINER
- 05 May 2026 — APPLICATION FILING RECEIPT MAILED
- 05 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 May 2026 — NEW APPLICATION ENTERED